Final Analyses of the Prospective Controlled Trial on the Efficacy of Uracil and Tegafur/leucovorin As an Adjuvant Treatment for Stage II Colon Cancer with Risk Factors for Recurrence Using Propensity Score-Based Methods (JFMC46-1201).
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY(2024)
Key words
Adjuvant chemotherapy,Colon cancer,High-risk stage II,Propensity score,Risk factor,Tegafur,Uracil,Leucovorin,Inverse probability of treatment-weighting
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined